Page last updated: 2024-11-07

rs 2135

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

RS 2135: structure given in first source; RN given refers to (mono-HCl;3aR-(3aalpha,12alpha,12aalpha,12balpha)-isomer); RN for parent cpd without isomeric designation not available 3/93 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159591
CHEMBL ID556801
MeSH IDM0198761

Synonyms (10)

Synonym
133775-36-7
isoquino(2,1,8-1ma)carbazol-5(1h)-one, 12-amino-2,3,3a,4,11,12,12a,12b-octahydro-10-hydroxy-, monohydrochloride,(3ar-(3aalpha,12alpha,12aalpha,12balpha))-
rs 2135
CHEMBL556801
(3ar,12r,12ar,12bs)-12-amino-2,3,3a,4,11,12,12a,12b-octahydro-10-hydroxy isoquino [2,1,8-lma]carbazol-5(1h)-one hydrochloride
DTXSID70928267
12-amino-10-hydroxy-2,3,3a,4,11,12,12a,12b-octahydroisoquinolino[2,1,8-lma]carbazol-5(1h)-one--hydrogen chloride (1/1)
(10r,11r,15r,19s)-10-amino-6-hydroxy-1-azapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2(7),3,5,8(18)-tetraen-17-one;hydrochloride
(3ar,3a1s,12r,12ar)-12-amino-10-hydroxy-2,3,3a,3a1,4,11,12,12a-octahydroisoquinolino[2,1,8-lma]carbazol-5(1h)-one hydrochloride
AKOS040747434
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID112265Antiarrhythmic activity in chloroform induced ventricular arrhythmia in mice, 15 min before exposure to chloroform intraperitoneal administration1992Journal of medicinal chemistry, Mar-06, Volume: 35, Issue:5
Synthesis and biological action of the aminotetrahydroisoquinocarbazoles and related compounds: a new class of compounds with antiarrhythmic activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (85.71)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.10 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]